Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

NCT02316899 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome With Constipation (IBS-C)

Interventions

DRUG: linaclotide
DRUG: Placebo

Sponsor

Astellas Pharma Inc